Led by $80m venture financing of Proximie, total medical devices industry venture financing deals worth $569m were announced in Europe in Q2 2022, according to GlobalData’s deals database.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 36.9% over the previous quarter and a drop of 42.5% when compared with the last four-quarter average of $989.48m.

Europe held a 12.73% share of the global medical devices industry venture financing deal value that totalled $4.47bn in Q2 2022. With a 4.53% share and deals worth $202.39m, France was the top country in Europe’s venture financing deal value across medical devices industry.

In terms of deal activity, Europe recorded 64 deals during Q2 2022, marking a decrease of 17.95% over the previous quarter and a rise of 7.56% over the last four-quarter average. The UK recorded 11 deals during the month.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Europe medical devices industry venture financing deals in Q2 2022: Top deals

The top five venture financing deals accounted for 49.4% of the overall value during Q2 2022.

The combined value of the top five medical devices venture financing deals stood at $281.15m, against the overall value of $569m recorded for the quarter.

The top five medical devices deals of Q2 2022 tracked by GlobalData were:

1) Advent Life Sciences,British Patient Capital,Eight Roads Ventures,Emerson Collective,F Prime Capital,Global ventures,Maverick Ventures Israel,Minderoo Foundation,Mubadala Investment,Questa Capital Management and SoftBank Vision Fund 2 $80m venture financing deal with Proximie

2) The $75.34m venture financing of Diabeloop by Innovacom,LBO France and Terumo

3) 3VC Partners,Balderton Capital,Eurazeo,heal.capital Management,Picus Capital and Vorwerk Ventures $54.73m venture financing deal with Avi Medical

4) The $39.77m venture financing of LimFlow by BPI France,Longitude Capital Management Co,Sofinnova Partners and Soleus Capital Management

5) Cathay Capital (China),GT Healthcare Capital Partners,JJDC,Johnson & Johnson Innovation – JJDC,Richard Leparmentier,Sacha Loiseau,Siddarth Satish,Sofinnova Partners and Yann Fleureau $31.3m venture financing deal with Moon Surgical